Frequency Therapeutics, Inc. (FREQ) Analyst Estimates Annual - Discounting Cash Flows
FREQ
Frequency Therapeutics, Inc.
FREQ (NASDAQ)
Period Ending: 2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Number of Analysts 1 2 2 0 1 1 0
Estimated Revenue
Low 0 0 0 0 63.14 44.17 54.61
Average 0 0 0 0 57.66 40.34 49.87
High 0 0 0 0 52.18 36.5 45.13
Estimated EBITDA
Low 0 0 0 0 -5.89 -4.12 -5.09
Average 0 0 0 0 -5.38 -3.76 -4.65
High 0 0 0 0 -4.87 -3.4 -4.21
Estimated EBIT
Low 0 0 0 0 -5.8 -4.06 -5.01
Average 0 0 0 0 -5.29 -3.7 -4.58
High 0 0 0 0 -4.79 -3.35 -4.14
Estimated Net Income
Low -43.84 -50.86 -49.11 -102.4 -37.67 -42.78 61.22
Average -57.3 -44 -50.45 -91.55 -33.67 -38.23 54.72
High -43.84 -29.11 -49.11 -80.67 -29.67 -33.69 48.22
Estimated SGA Expenses
Low 0 0 0 0 59.77 41.82 51.7
Average 0 0 0 0 54.58 38.19 47.21
High 0 0 0 0 49.4 34.56 42.72
Estimated EPS
Low -1.25 -1.45 -1.4 -2.92 -1.07 -1.22 1.75
Average -1.25 -1.14 -1.4 -2.61 -0.96 -1.09 1.56
High -1.25 -0.83 -1.4 -2.3 -0.846 -0.96 1.37
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program